As of 28 Aug 2026, Ipca Laboratories Ltd share price is ₹1,958.65. The stock opened at ₹1,958.65 and had closed at ₹1,951.90 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,252.95 and a high of ₹1,990.05. In terms of performance, Ipca Laboratories Ltd share price has increased by 28.48% over the past six months and has increased by 41.84% over the last year.
IPCALAB Charts
Ipca Laboratories Ltd Overview
About IPCALAB
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical ingredients (APIs).
Ipca Laboratories Ltd Historical Performance
Ipca Laboratories Ltd Fundamental Analysis
Ipca Laboratories Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 2,136.66 | 1,844.23 | 1,863.00 | 1,952.24 | 1,771.92 |
| EBITDA | 595.06 | 430.64 | 495.30 | 486.63 | 431.94 |
| Net Profit | 373.29 | 262.29 | 303.45 | 304.74 | 262.04 |
| EPS | 14.71 | 11.54 | 11.96 | 12.01 | 10.33 |
Ipca Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 67.86 |
| MACD | 49.92 |
| 20-Day SMA | 1,808.77 |
Ipca Laboratories Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Ipca Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Ipca Laboratories Ltd today is ₹1,958.65 on NSE and ₹1,958.65 on BSE.
- The 52-week high of Ipca Laboratories Ltd is ₹1,990.05, while the 52-week low is ₹1,252.95.
- The current market capitalisation of Ipca Laboratories Ltd is approximately ₹49,692 crore.
- The P/E (Price-to-Earnings) ratio of Ipca Laboratories Ltd is 39.80. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Ipca Laboratories Ltd is 5.04. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Ipca Laboratories Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Ipca Laboratories Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Ipca Laboratories Ltd has delivered a return of approximately 119.38%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Ipca Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 44.72% promoters, -20.42% FIIs, 37.37% DIIs, and 5.76% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
